Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis

被引:36
|
作者
Möller, B
Kukoc-Zivojnov, N
Kessler, U
Rehart, S
Kaltwasser, JP
Hoelzer, D
Kalina, U
Ottmann, OG
机构
[1] Univ Frankfurt Klinikum, Med Klin 3, Ctr Rheumat Dis, Lab B2 19 20, D-64686 Lautertal, Germany
[2] Univ Frankfurt Klinikum, Dept Internal Med, D-64686 Lautertal, Germany
[3] Univ Frankfurt Klinikum, Dept Arthrit Surg, D-64686 Lautertal, Germany
关键词
rheumatoid arthritis; IL-18; fibroblast-like synoviocytes; PBMC; cytokines;
D O I
10.1093/rheumatology/40.3.302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate the expression of and monokine induction by interleukin 18 (IL-18; also called interferon-gamma inducing factor, IGIF), in peripheral blood mononuclear cells (PBMC) and cultured synoviocytes from rheumatoid arthritis (RA) patients. Methods. We carried out IL-18 Western blotting and semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) of cytokines in PBMC [IL-18, IL-1 beta and tumour necrosis factor alpha (TNF-alpha)] and long-term cultured fibroblast-like synoviocytes (FLS) [IL-18, IL-1 beta, TNF-alpha, IL-6, interferon gamma (INF-gamma) and [granulocyte-macrophage colony stimulating factor (GM-CSF)] from RA patients and controls. FLS were isolated from RA synovial membranes (FLSSM) and RA synovial fluids (FLSSF), osteoarthritis (OA) FLSSM and FLSSF: from spondyloarthropathy patients. FLS were characterized by fluorescence-activated cell sorting of the FLS. PBMC and FLS from RA patients and control subjects were stimulated with recombinant human IL-18 and IL-1 beta (rHuIL-18/rHuIL-1 beta), and TNF-alpha, IL-1 beta and MMP-1 were measured by ELISA in supernatants. Results. Constitutive expression of IL-18 mRNA was significantly reduced whereas that of TNF-alpha was enhanced in RA PBMC. Persistent low expression of IL-18, TNF-alpha, GM-CSF and IL-1 beta was observed in RA and OA FLSSM as well as spondyloarthropathy FLSSF. In contrast, high constitutive expression of IL-18 in FLS (CD90/Thy-1- and CD54-positive, CD14- and CD86-negative), accompanied by persistent high levels of TNF-alpha, GM-CSF and IL-1 beta expression, was restricted to synovial fluid-derived FLS obtained from RA patients. IFN-gamma was not detectable in any culture, but IL-6 mRNA was equally expressed in all FLS cultures. rHuIL-18 was effective in stimulating TNF-alpha and IL-1 beta secretion in PBMC from healthy controls, but failed to stimulate TNF-alpha and IL-1 beta secretion from PBMC in 11 of 12 RA patients, and all FLS cultures. rHu-IL-1 beta, but not rHu-IL-18, induced interstitial collagenase (MMP-1) in FLS. Conclusions. Persistent high production of proinflammatory cytokines in RA-FLSSF may be relevant for chronic progression in RA synovitis. Levels of TNF-alpha and IL-1 beta expression are increased in RA-FLSSF, but are independent of IL-18. The pathological function of enhanced IL-18 expression in RA-FLSSF remains to be further elucidated.
引用
收藏
页码:302 / 309
页数:8
相关论文
共 50 条
  • [1] Expression and function interleukin-18 in synovial tissue of patients with rheumatoid arthritis.
    Tanaka, M
    Harigai, M
    Kawaguchi, Y
    Sugiura, T
    Ohta, S
    Takagi, K
    Fukasawa, C
    Hara, M
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S250 - S250
  • [2] Interleukin-18 and the treatment of rheumatoid arthritis
    Dinarello, CA
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 417 - +
  • [3] Interleukin-18: a therapeutic target in rheumatoid arthritis?
    Iain B McInnes
    Foo Y Liew
    J Alastair Gracie
    Arthritis Res Ther, 7
  • [4] Is interleukin-18 useful for monitoring rheumatoid arthritis?
    Bokarewa, M
    Hultgren, O
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (06) : 433 - 436
  • [5] Interleukin-18, rheumatoid arthritis, and tissue destruction
    Dayer, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10): : 1337 - 1339
  • [6] Cellular targets of interleukin-18 in rheumatoid arthritis
    Dai, Sheng-Ming
    Shan, Zheng-Zheng
    Xu, Huji
    Nishioka, Kusuki
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) : 1411 - 1418
  • [7] Interleukin-18 (IL-18) in rheumatoid arthritis (RA)
    Gracie, JA
    Forsey, RJ
    Gilmour, A
    Chan, L
    Field, M
    Liew, FY
    Sturrock, RD
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S297 - S297
  • [8] Interleukin-18: A therapeutic target in rheumatoid arthritis? Commentary
    McInnes, IB
    Liew, FY
    Gracie, JA
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (01) : 38 - 41
  • [9] Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis
    Pawlik, A
    Kurzawski, M
    Czerny, B
    Gawronska-Szklarz, B
    Drozdzik, M
    Herczynska, M
    TISSUE ANTIGENS, 2006, 67 (05): : 415 - 418
  • [10] Interleukin-18: A Mediator of Inflammation and Angiogenesis in Rheumatoid Arthritis
    Volin, Michael V.
    Koch, Alisa E.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (10): : 745 - 751